Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
84.00
-1.16 (-1.36%)
Aug 12, 2026, 11:08 AM EDT - Market open

Globus Medical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
507.75526.16784.44467.29150.47193.07
Short-Term Investments
87.431.09105.6250.5295.59250.38
Cash & Short-Term Investments
595.14557.24890.06517.79446.06443.45
Cash Growth
159.38%-37.39%71.90%16.08%0.59%3.91%
Accounts Receivable
692.18678.94557.7503.24213.25164.44
Other Receivables
47.164.7320.631.644.061.22
Total Trade Receivables
739.28743.67578.33504.87217.31165.65
Inventory
810.9759.28659.23848.14298.98237
Other Current Assets
70.265.4349.6444.582118.42
Total Current Assets
2,2162,1262,1771,915983.34864.52
Net Property, Plant & Equipment
592.68628.24611.56646.86249.72221.08
Other Intangible Assets
692.62745.06795.12924.663.5768.66
Goodwill
1,4381,4351,4321,435197.47179.71
Long-Term Investments
245.3671.8266.1375.43495.85562.48
Other Long-Term Assets
303.87297169.389.2886.1760.83
Total Assets
5,4885,3035,2525,0862,0761,957

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
106.9498.8575.1256.6736.121.96
Accrued Expenses
306.76337.74271.32244.3193.1692.21
Short-Term Debt
--443.35---
Current Portion of Leases
14.3914.7410.2511.972.54-
Unearned Revenue
27.9827.6622.1418.3714.112.03
Other Current Liabilities
23.2819.5133.7461.0413.3113.97
Total Current Liabilities
479.35498.5855.91392.35159.2140.16
Long-Term Debt
---417.4--
Long-Term Leases
96.81103.9283.5991.043.48-
Other Long-Term Liabilities
143.5127.09134.92187.3467.0775.71
Total Long-Term Liabilities
240.31231.01218.5695.7870.5575.71
Total Liabilities
719.66729.511,0741,088229.75215.88

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.130.140.140.140.10.1
Additional Paid-in Capital
3,2303,1703,0312,871630.95553.79
Accumulated Other Comprehensive Income
11.215.35-6.86-10.19-24.63-6.77
Retained Earnings
1,5271,3881,1531,1371,2401,194
Shareholders' Equity
4,7694,5734,1773,9981,8461,741
Total Liabilities & Equity
5,4885,3035,2525,0862,0761,957

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
111.19118.66537.19520.46.010
Net Cash (Debt)
483.95438.59352.87-2.62440.05443.45
Net Cash Growth
346.69%24.29%---0.77%3.91%
Net Cash Per Share
3.543.202.56-0.024.294.28
Book Value
4,7694,5734,1773,9981,8461,741
Book Value Per Share
34.8433.3730.3034.8817.9916.80
Tangible Book Value
2,6382,3931,9501,6391,5851,493
Tangible Book Value Per Share
19.2717.4614.1414.3015.4514.41
SEC Filings: 10-K · 10-Q